CBD Suppresses HER2-Positive Breast Cancer Receptor and Increases Cancer Cell Death in Preclinical Study
A preclinical study published in BMC Complementary Medicine reported that CBD reduced expression of a receptor associated with HER2-positive breast cancer and increased cancer-cell death by activating cellular stress pathways. The work also examined potential combination use with trastuzumab, but further validation is needed because the evidence remains at the cell-study stage.
For the full article, please visit the original source link below. CannabisInsight curates and summarizes key news from the global cannabis and hemp industry.
Source
themarijuanaherald.com
This content is a summary and editorial by CannabisInsight based on the above source. Copyright of the original article belongs to the respective publisher.
Original Link
https://themarijuanaherald.com/2026/08/study-finds-cbd-suppresses-her2-breast-cancer-receptor-and-increases-cancer-cell-death/